ANTI-CD20 ANTIBODY-DRUG CONJUGATES FOR THE TREATMENT OF CANCER AND IMMUNE DISORDERS

Details for Australian Patent Application No. 2003294210 (hide)

Owner SEATTLE GENETICS, INC.

Inventors Wahl, Alan F.; Senter, Peter D.; Law, Che-Leung; Cerveny, Charles G.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2003294210

PCT Number PCT/US2003/0238

PCT Pub. Number WO2004/032828

Priority 60/400,404 31.07.02 US

Filing date 30 July 2003

Wipo publication date 4 May 2004

Event Publications

22 April 2004 Complete Application Filed

  Priority application(s): 60/400,404 31.07.02 US

3 June 2004 Application Open to Public Inspection

  Published as AU-A-2003294210

5 April 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003294211-METHOD AND SYSTEM FOR MANAGING AND QUERYING GENE EXPRESSION DATA ACCORDING TO QUALITY

2003294209-METHODS AND REAGENTS FOR IDENTIFYING INHIBITORS OF VIRAL PROTEASE ACTIVITY.